Fate Therapeutics Inc (FATE)
4.06
-0.04
(-0.98%)
USD |
NASDAQ |
May 03, 16:00
4.06
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Market Cap: 402.90M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 402.90M |
| May 02, 2024 | 406.87M |
| May 01, 2024 | 405.88M |
| April 30, 2024 | 391.99M |
| April 29, 2024 | 400.92M |
| April 26, 2024 | 377.10M |
| April 25, 2024 | 384.05M |
| April 24, 2024 | 426.72M |
| April 23, 2024 | 450.54M |
| April 22, 2024 | 474.36M |
| April 19, 2024 | 475.35M |
| April 18, 2024 | 500.16M |
| April 17, 2024 | 522.98M |
| April 16, 2024 | 533.90M |
| April 15, 2024 | 559.70M |
| April 12, 2024 | 572.60M |
| April 11, 2024 | 590.46M |
| April 10, 2024 | 622.22M |
| April 09, 2024 | 670.85M |
| April 08, 2024 | 665.88M |
| April 05, 2024 | 686.72M |
| April 04, 2024 | 691.69M |
| April 03, 2024 | 695.65M |
| April 02, 2024 | 674.82M |
| April 01, 2024 | 702.60M |
| Date | Value |
|---|---|
| March 28, 2024 | 728.40M |
| March 27, 2024 | 728.40M |
| March 26, 2024 | 680.77M |
| March 25, 2024 | 681.76M |
| March 22, 2024 | 655.96M |
| March 21, 2024 | 737.33M |
| March 20, 2024 | 737.33M |
| March 19, 2024 | 694.66M |
| March 18, 2024 | 698.63M |
| March 15, 2024 | 743.29M |
| March 14, 2024 | 717.49M |
| March 13, 2024 | 758.17M |
| March 12, 2024 | 760.16M |
| March 11, 2024 | 782.98M |
| March 08, 2024 | 805.81M |
| March 07, 2024 | 828.63M |
| March 06, 2024 | 791.92M |
| March 05, 2024 | 687.72M |
| March 04, 2024 | 702.60M |
| March 01, 2024 | 768.10M |
| February 29, 2024 | 703.59M |
| February 28, 2024 | 708.56M |
| February 27, 2024 | 740.31M |
| February 26, 2024 | 689.70M |
| February 23, 2024 | 690.69M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
162.67M
Minimum
Oct 27 2023
10.90B
Maximum
Jan 14 2021
2.942B
Average
2.126B
Median
Jun 06 2022
Market Cap Benchmarks
| Amicus Therapeutics Inc | 3.072B |
| Sarepta Therapeutics Inc | 12.63B |
| ADMA Biologics Inc | 1.554B |
| Ocular Therapeutix Inc | 917.03M |
| Viking Therapeutics Inc | 8.487B |
Market Cap Related Metrics
| PS Ratio | 6.289 |
| Price to Book Value | 1.094 |
| Price | 4.06 |
| Earnings Yield | -40.39% |